This Article OPEN ACCESS ARTICLE Full Text Full Text (PDF) All Versions of this Article: gr.5558208v1 18/3/343    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Belancio, V. P. Articles by Deininger, P. PubMed PubMed Citation Articles by Belancio, V. P. Articles by Deininger, P. Social Bookmarking                   What's this?

Review

Mammalian non-LTR retrotransposons: For better or worse, in sickness and in health

Tulane Cancer Center and Department of Epidemiology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA

Transposable elements (TEs) have shared an exceptionally long coexistence with their host organisms and have come to occupy a significant fraction of eukaryotic genomes. The bulk of the expansion occurring within mammalian genomes has arisen from the activity of type I retrotransposons, which amplify in a "copy-and-paste" fashion through an RNA intermediate. For better or worse, the sequences of these retrotransposons are now wedded to the genomes of their mammalian hosts. Although there are several reported instances of the positive contribution of mobile elements to their host genomes, these discoveries have occurred alongside growing evidence of the role of TEs in human disease and genetic instability. Here we examine, with a particular emphasis on human retrotransposon activity, several newly discovered aspects of mammalian retrotransposon biology. We consider their potential impact on host biology as well as their ultimate implications for the nature of the TE–host relationship.

E-mail pdeinin{at}tulane.edu; fax (504) 988-5516.

Article published online before print. Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.5558208

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?